132 related articles for article (PubMed ID: 17130205)
1. Plasma metallothionein antibody, urinary cadmium, and renal dysfunction in a Chinese type 2 diabetic population.
Chen L; Lei L; Jin T; Nordberg M; Nordberg GF
Diabetes Care; 2006 Dec; 29(12):2682-7. PubMed ID: 17130205
[TBL] [Abstract][Full Text] [Related]
2. Plasma metallothionein antibody and cadmium-induced renal dysfunction in an occupational population in China.
Chen L; Jin T; Huang B; Chang X; Lei L; Nordberg GF; Nordberg M
Toxicol Sci; 2006 May; 91(1):104-12. PubMed ID: 16322080
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between plasma anti-metallothionein antibody and renal dysfunction in cadmium exposed workers].
Chen L; Jin TY; Chang XL; Lei LJ; Zhou YF
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2006 Jan; 24(1):7-11. PubMed ID: 16600085
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of kidney dysfunction in humans - relationship to cadmium dose, metallothionein, immunological and metabolic factors.
Nordberg GF; Jin T; Wu X; Lu J; Chen L; Lei L; Hong F; Nordberg M
Biochimie; 2009 Oct; 91(10):1282-5. PubMed ID: 19563860
[TBL] [Abstract][Full Text] [Related]
5. Striking association between urinary cadmium level and albuminuria among Torres Strait Islander people with diabetes.
Haswell-Elkins M; Satarug S; O'Rourke P; Moore M; Ng J; McGrath V; Walmby M
Environ Res; 2008 Mar; 106(3):379-83. PubMed ID: 18045586
[TBL] [Abstract][Full Text] [Related]
6. High prevalence of albuminuria in population-based patients diagnosed with type 2 diabetes in the Shanghai downtown.
Lu B; Wen J; Song XY; Dong XH; Yang YH; Zhang ZY; Zhao NQ; Ye HY; Mou B; Chen FL; Liu Y; Shen Y; Wang XC; Zhou LN; Li YM; Zhu XX; Hu RM
Diabetes Res Clin Pract; 2007 Feb; 75(2):184-92. PubMed ID: 16893584
[TBL] [Abstract][Full Text] [Related]
7. Critical exposure level of cadmium for elevated urinary metallothionein--an occupational population study in China.
Chen L; Jin T; Huang B; Nordberg G; Nordberg M
Toxicol Appl Pharmacol; 2006 Aug; 215(1):93-9. PubMed ID: 16510161
[TBL] [Abstract][Full Text] [Related]
8. Cadmium-exposed population in Mae Sot District, Tak Province: 2. Prevalence of renal dysfunction in the adults.
Limpatanachote P; Swaddiwudhipong W; Mahasakpan P; Krintratun S
J Med Assoc Thai; 2009 Oct; 92(10):1345-53. PubMed ID: 19845243
[TBL] [Abstract][Full Text] [Related]
9. Metallothionein I isoform mRNA expression in peripheral lymphocytes as a biomarker for occupational cadmium exposure.
Chang X; Jin T; Chen L; Nordberg M; Lei L
Exp Biol Med (Maywood); 2009 Jun; 234(6):666-72. PubMed ID: 19359654
[TBL] [Abstract][Full Text] [Related]
10. Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients.
Leitão CB; Canani LH; Kramer CK; Boza JC; Pinotti AF; Gross JL
Diabetes Care; 2007 May; 30(5):1255-60. PubMed ID: 17303786
[TBL] [Abstract][Full Text] [Related]
11. [Chronic renal disease in diabetic and prediabetic subjects: a community-based study in Shanghai].
Wang WX; Jia WP; Bao YQ; Lu JX; Lu HJ; Zuo YH; Du J; Liu LH; Fang R; Xiang KS
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2527-32. PubMed ID: 17198559
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of exposure, effects and susceptibility in humans and their application in studies of interactions among metals in China.
Nordberg GF
Toxicol Lett; 2010 Jan; 192(1):45-9. PubMed ID: 19540908
[TBL] [Abstract][Full Text] [Related]
13. Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus.
Hsieh MC; Tien KJ; Perng DS; Hsiao JY; Chang SJ; Liang HT; Chen HC; Tu ST
Metabolism; 2009 Apr; 58(4):504-9. PubMed ID: 19303971
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein gene expression in peripheral lymphocytes and renal dysfunction in a population environmentally exposed to cadmium.
Lu J; Jin T; Nordberg G; Nordberg M
Toxicol Appl Pharmacol; 2005 Aug; 206(2):150-6. PubMed ID: 15967203
[TBL] [Abstract][Full Text] [Related]
15. Kidney dysfunction and cadmium exposure--factors influencing dose-response relationships.
Nordberg G; Jin T; Wu X; Lu J; Chen L; Liang Y; Lei L; Hong F; Bergdahl IA; Nordberg M
J Trace Elem Med Biol; 2012 Jun; 26(2-3):197-200. PubMed ID: 22565016
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
Bleyer AJ; Sedor JR; Freedman BI; O'Brien A; Russell GB; Graley J; Schelling JR
Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
[TBL] [Abstract][Full Text] [Related]
17. Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan.
Kobayashi E; Suwazono Y; Uetani M; Inaba T; Oishi M; Kido T; Nishijo M; Nakagawa H; Nogawa K
Environ Res; 2006 Jul; 101(3):401-6. PubMed ID: 16436274
[TBL] [Abstract][Full Text] [Related]
18. Serum adiponectin and renal dysfunction in men with type 2 diabetes.
Lin J; Hu FB; Curhan G
Diabetes Care; 2007 Feb; 30(2):239-44. PubMed ID: 17259488
[TBL] [Abstract][Full Text] [Related]
19. Cigarette smoking is associated with low glomerular filtration rate in male patients with type 2 diabetes.
De Cosmo S; Lamacchia O; Rauseo A; Viti R; Gesualdo L; Pilotti A; Trischitta V; Cignarelli M
Diabetes Care; 2006 Nov; 29(11):2467-70. PubMed ID: 17065686
[TBL] [Abstract][Full Text] [Related]
20. Association of urinary cadmium and myocardial infarction.
Everett CJ; Frithsen IL
Environ Res; 2008 Feb; 106(2):284-6. PubMed ID: 18053980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
